IL-7 Receptor Polymorphisms and Immune Recovery With HAART

NCT00168207 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 106

Last updated 2012-01-20

No results posted yet for this study

Summary

The aim is to investigate the hypothesis that IL7-receptor polymorphisms contribute to the differential immune recovery of CD4 + T cells following HAART

Conditions

  • HIV Infections

Sponsors & Collaborators

  • National Health and Medical Research Council, Australia

    collaborator OTHER
  • The Alfred

    lead OTHER

Principal Investigators

  • Jennifer Hoy, A/Prof · The Alfred

  • Sharon Lewin, Professor · Alfred Hospital, Melbourne, Vic 3004

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-05-31
Completion
2009-05-31

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00168207 on ClinicalTrials.gov